| Methods to increase response to postal and electronic questionnaires PJ Edwards, I Roberts, MJ Clarke, C DiGuiseppi, B Woolf, C Perkins Cochrane database of systematic reviews, 2023 | 2449 | 2023 |
| Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement VW Skrivankova, RC Richmond, BAR Woolf, J Yarmolinsky, NM Davies, ... Jama 326 (16), 1614-1621, 2021 | 2055 | 2021 |
| Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration VW Skrivankova, RC Richmond, BAR Woolf, NM Davies, SA Swanson, ... bmj 375, 2021 | 943 | 2021 |
| STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies GD Smith, NM Davies, N Dimou, M Egger, V Gallo, R Golub, JPT Higgins, ... PeerJ Preprints, 2019 | 117 | 2019 |
| Major depression and secondhand smoke exposure SB Patten, JVA Williams, DH Lavorato, B Woolf, JL Wang, AGM Bulloch, ... Journal of affective disorders 225, 260-264, 2018 | 48 | 2018 |
| Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform B Woolf, N Di Cara, C Moreno-Stokoe, V Skrivankova, K Drax, ... International Journal of Epidemiology 51 (6), 1943-1956, 2022 | 38 | 2022 |
| Plasma caffeine levels and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomization study SC Larsson, B Woolf, D Gill Nutrients 14 (9), 1697, 2022 | 38 | 2022 |
| MendelianRandomization v0. 9.0: updates to an R package for performing Mendelian randomization analyses using summarized data A Patel, T Ye, H Xue, Z Lin, S Xu, B Woolf, AM Mason, S Burgess Wellcome Open Research 8, 2023 | 36 | 2023 |
| Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study SC Larsson, B Woolf, D Gill BMJ medicine 2 (1), 1, 2023 | 36 | 2023 |
| Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study M Ardissino, EAW Slob, S Rajasundaram, RK Reddy, B Woolf, J Girling, ... BMC medicine 20 (1), 288, 2022 | 30 | 2022 |
| TwoStepCisMR: A Novel Method and R Package for Attenuating Bias in cis-Mendelian Randomization Analyses B Woolf, L Zagkos, D Gill Genes 13 (9), 1541, 2022 | 29 | 2022 |
| A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study B Woolf, S Rajasundaram, HT Cronjé, J Yarmolinsky, S Burgess, D Gill bmj 383, 2023 | 17 | 2023 |
| Lipids, blood pressure, and diabetes mellitus on risk of cardiovascular diseases in East Asians: A Mendelian randomization study JL Ciofani, D Han, UK Allahwala, B Woolf, D Gill, R Bhindi The American journal of cardiology 205, 329-337, 2023 | 15 | 2023 |
| Morning cortisol and circulating inflammatory cytokine levels: A Mendelian randomisation study S Rajasundaram, RP Rahman, B Woolf, SS Zhao, D Gill Genes 13 (1), 116, 2022 | 13 | 2022 |
| Triangulating evidence for the causal impact of single-intervention zinc supplement on glycaemic control for type 2 diabetes: systematic review and meta-analysis of randomised … Z Wang, C Ronsmans, B Woolf British Journal of Nutrition 129 (11), 1929-1944, 2023 | 12 | 2023 |
| Does advance contact with research participants increase response to questionnaires: an updated systematic review and meta-analysis B Woolf, P Edwards BMC medical research methodology 21, 1-27, 2021 | 11* | 2021 |
| Addressing the credibility crisis in Mendelian randomization S Burgess, B Woolf, AM Mason, M Ala-Korpela, D Gill BMC medicine 22 (1), 374, 2024 | 10 | 2024 |
| Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target Mendelian randomization B Woolf, HT Cronjé, L Zagkos, SC Larsson, D Gill, S Burgess American Journal of Epidemiology, kwae143, 2024 | 9* | 2024 |
| Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization B Woolf, HT Cronjé, L Zagkos, S Burgess, D Gill, SC Larsson BMC medicine 21 (1), 296, 2023 | 9 | 2023 |
| Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants AS Bhagavathula, B Woolf, J Rahmani, K Vidyasagar, W Tesfaye European Journal of Clinical Pharmacology 78 (4), 547-555, 2022 | 9 | 2022 |
James YarmolinskyImperial College LondonVerified email at imperial.ac.uk